Published 60 Day FRN

36065

Federal Register / Vol. 79, No. 122 / Wednesday, June 25, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent

Total ...........................................

Total
burden
hours

1

2

800

...........................................................

........................

........................

........................

1,680

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–14–0870]

Proposed Data Collections Submitted
for Public Comment and
Recommendations

mstockstill on DSK4VPTVN1PROD with NOTICES

Average
burden per
response
(in hours)

400

[FR Doc. 2014–14834 Filed 6–24–14; 8:45 am]

The Centers for Disease Control and
Prevention (CDC), as part of its
continuing effort to reduce public
burden, invites the general public and
other Federal agencies to take this
opportunity to comment on proposed
and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995. To
request more information on the below
proposed project or to obtain a copy of
the information collection plan and
instruments, call 404–639–7570 or send
comments to Leroy Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget (OMB)
approval. Comments are invited on: (a)
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,

18:01 Jun 24, 2014

Number of
responses per
respondent

Focus Group Discussion Guide .......

Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.

VerDate Mar<15>2010

Number of
respondents

Form name

Jkt 232001

maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. Written comments should
be received within 60 days of this
notice.
Proposed Project
Monitoring and Reporting System for
Chronic Disease Prevention and Control
Programs (OMB No. 0920–0870, exp.
11/30/2014)—Revision—National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Tobacco use is the single most
preventable cause of death and disease
in the United States. Tobacco use causes
heart disease and strokes, lung cancer
and many other types of cancer, chronic
obstructive pulmonary disease, lung
disorders, pregnancy problems, sudden
infant death syndrome, gum disease,
and vision problems. Approximately
480,000 Americans die from tobaccorelated illnesses annually, a higher
number of deaths than the combined
total deaths from HIV/AIDS, alcohol
use, cocaine use, heroin use, homicides,
suicides, motor vehicle crashes, and
fires. For every person who dies from
tobacco use, 20 more people suffer with
at least one serious tobacco-related
illness. There are also severe economic
consequences of tobacco use as the U.S.
spends approximately $280 billion
annually in direct medical expenses and

PO 00000

Frm 00078

Fmt 4703

Sfmt 4703

lost productivity attributable to the
effects of tobacco use.
The National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP) provides
funding to health departments in States,
territories, and the District of Columbia
to implement and evaluate chronic
disease prevention and control
programs, including tobacco control
programs. Currently, CDC has
cooperative agreements to support
tobacco control programs in all 50 states
and the District of Columbia under FOA
DP14–1415, an extension of FOA DP09–
901. These cooperative agreements
technically ended on March 28, 2014,
however a one-year cost extension
(DP14–1415) was granted. Due to the
cost extension, final reports on awardee
activities are due to CDC approximately
90 days after the end of the funding
period (June 26, 2015).
In order to maintain continuity in
progress reporting through the end of
the cost extension, CDC requests OMB
approval to continue the collection of
information from tobacco control
program awardees for one year.
Awardees will continue to submit semiannual progress reports through a Webbased management information system
(MIS).
CDC will continue to collect
information about each awardee’s
tobacco control objectives, planning,
activities, resources, partnerships,
strategies, and progress toward meeting
objectives. Awardees will use the
information reported through the
electronic MIS to manage and
coordinate their activities and to
improve their efforts. CDC will use the
information reported through the MIS to
document and monitor each awardee’s
progress and to make adjustments, as
needed, in the type and level of
technical assistance provided to them.
The information collection allows CDC
to oversee the use of federal funds, and
identify and disseminate information
about successful tobacco control
strategies implemented by awardees.
CDC also uses the information to
respond to Congressional and
stakeholder inquiries about awardee

E:\FR\FM\25JNN1.SGM

25JNN1

36066

Federal Register / Vol. 79, No. 122 / Wednesday, June 25, 2014 / Notices

activities, program implementation, and
program impact.
Progress reporting through the MIS is
required for CDC funded awardees.
There are no costs to respondents other
than their time. There are no changes to
the content of the information

collection, the frequency of information
collection, or the estimated burden per
response. The only change is a decrease
in the number of tobacco control
program respondents from 53 to 51.
Puerto Rico and the Virgin Islands were

originally funded under DP09–901 but
discontinued their participation under
the DP14–1415 cost extension. As a
result, the total estimated annualized
burden hours will decrease from 636 to
612.

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)

Total
burden
hours

Form name

State Tobacco Control Program .......

Management Information System ....

51

2

6

612

Total ...........................................

...........................................................

........................

........................

........................

612

Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–14788 Filed 6–24–14; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–14–0773]

Proposed Data Collections Submitted
for Public Comment and
Recommendations

mstockstill on DSK4VPTVN1PROD with NOTICES

Number of
responses per
respondent

Number of
respondents

Type of respondent

The Centers for Disease Control and
Prevention (CDC), as part of its
continuing effort to reduce public
burden, invites the general public and
other Federal agencies to take this
opportunity to comment on proposed
and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995. To
request more information on the below
proposed project or to obtain a copy of
the information collection plan and
instruments, call 404–639–7570 or send
comments to Leroy Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget (OMB)
approval. Comments are invited on: (a)
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the

VerDate Mar<15>2010

18:01 Jun 24, 2014

Jkt 232001

quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Surveillance for Severe
Adverse Events Associated with
Treatment of Latent Tuberculosis
Infection (OMB No. 0920–0773, expires
11/30/2014)—Extension—Division of
Tuberculosis Elimination (DTBE),
National Center for HIV, Viral Hepatitis,
STD, and TB Prevention NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
As part of the national tuberculosis
(TB) elimination strategy, the American
Thoracic Society and CDC have
published recommendations for targeted
testing for TB and treatment for latent
TB infection (LTBI) (Morbidity and

PO 00000

Frm 00079

Fmt 4703

Sfmt 4703

Mortality Weekly Report (MMWR)
2000;49[RR06];1–54). However, between
October 2000 and September 2004, the
CDC received reports of 50 patients with
severe adverse events (SAEs) associated
with the use of the two or three-month
regimen of rifampin and pyrazinamide
(RZ) for the treatment of LTBI; 12 (24%)
patients died (MMWR 2003;52[31]:735–
9).
In 2004, CDC began collecting reports
of SAEs associated with any treatment
regimen for LTBI. For surveillance
purposes, an SAE was defined as any
drug-associated reaction resulting in a
patient’s hospitalization or death after at
least one treatment dose for LTBI.
During 2004–2008, CDC received 17
reports of SAEs in 15 adults and two
children; all patients had received
isoniazid (INH) and had experienced
severe liver injury MMWR 2010;
59:224–9).
Reports of SAEs related to RZ and
INH have prompted a need for this
project (a national surveillance system
of such events). The objective of the
project is to determine the annual
number and temporal trends of SAEs
associated with any treatment for LTBI
in the United States. Surveillance of
such events will provide data to support
periodic evaluation or potential revision
of guidelines for treatment of persons
with LTBI.
On December 9, 2011, CDC published
the Recommendations for Use of an
Isoniazid-Rifapentine Regimen with
Direct Observation to Treat Latent
Mycobacterium tuberculosis Infection in
MMWR 2011;60(48);1650–1653.
Isoniazid-Rifapentin (3HP) is a new
biweekly 3-month treatment regimen for
LTBI. Since 2011, there have been 28
reports of SAE; 26 of these were
associated with 3HP.
The CDC requests approval for a 3year extension of the previously
approved National Surveillance for
Severe Adverse Events Associated with

E:\FR\FM\25JNN1.SGM

25JNN1